Arava Bio Tech Ltd.: Clinical Trials

2 trials sponsored by Arava Bio Tech Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2

Follow Arava Bio Tech Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Topical AR/101 Compared With Placebo, in Accelerating Granulation Tissue Formation of Hard-to-heal Wounds
AR/101, Placebo - Wounds, Other Ulcers Wounds and Skin Problems
Phase 2UnknownArava Bio Tech Ltd.602016-08-012016-07-20
Safety and Efficacy of AR/101 in Accelerating Re-epithelialization of Split Thickness Wounds
AR/101, Placebo - Wounds and Injuries
Phase 2UnknownArava Bio Tech Ltd.182015-11-012016-07-19

Conditions studied

Wounds and Injuries (2)  ·  Diabetes Mellitus (1)  ·  Ulcer (1)  ·  Varicose Ulcer (1)

Countries

Israel (1)  ·  United States (1)

Top investigators

Robert Galiano, MD FACS (1)